200 related articles for article (PubMed ID: 27748273)
1. Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes.
Saksena A; Gautam P; Desai P; Gupta N; Dubey AP; Singh T
Indian J Med Res; 2016 May; 143(Supplement):S17-S22. PubMed ID: 27748273
[TBL] [Abstract][Full Text] [Related]
2. [CD45 gating for flow cytometric analysis of acute leukemia].
Miyazaki T; Nishikawa K; Noma Y; Tsukaguchi N; Nakagawa K; Kobayashi Y; Kohsaka T
Rinsho Ketsueki; 1996 Mar; 37(3):214-20. PubMed ID: 8727345
[TBL] [Abstract][Full Text] [Related]
3. Optimizing antibody panels for efficient and cost-effective flow cytometric diagnosis of acute leukemia.
Haycocks NG; Lawrence L; Cain JW; Zhao XF
Cytometry B Clin Cytom; 2011; 80(4):221-9. PubMed ID: 21298777
[TBL] [Abstract][Full Text] [Related]
4. Application of CD45/SSC gating multiparameter flow cytometry in the classification of acute leukemia--an analysis of 139 cases.
Li W; Chen Z; Liu Z; Zou P
J Tongji Med Univ; 2001; 21(3):209-11. PubMed ID: 12539578
[TBL] [Abstract][Full Text] [Related]
5. [Immunophenotyping of peripheral blood leukemic cells by multi-parameter cytometry].
Zhang T; Zhao LL; Zhang CQ; Xu CG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):225-7. PubMed ID: 15191732
[TBL] [Abstract][Full Text] [Related]
6. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
Wongprajun S; Auewarakul CU
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric characterization of phenotype, DNA indices and p53 gene expression in 55 cases of acute leukemia.
Powari M; Varma N; Varma S; Marwaha RK; Sandhu H; Ganguly NK
Anal Quant Cytol Histol; 2002 Jun; 24(3):159-65. PubMed ID: 12102128
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
Li X; Du W; Liu W; Li X; Li H; Huang SA
APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
[TBL] [Abstract][Full Text] [Related]
9. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
Zelezníková T; Babusíková O
Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
[TBL] [Abstract][Full Text] [Related]
10. Light scatter characteristics of blast cells in acute myeloid leukaemia: association with morphology and immunophenotype.
Vidriales MB; Orfao A; López-Berges MC; González M; López-Macedo A; García MA; Galende J; San Miguel JF
J Clin Pathol; 1995 May; 48(5):456-62. PubMed ID: 7629293
[TBL] [Abstract][Full Text] [Related]
11. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
Zelezníková T; Babusíková O
Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
[TBL] [Abstract][Full Text] [Related]
12. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia.
Lacombe F; Durrieu F; Briais A; Dumain P; Belloc F; Bascans E; Reiffers J; Boisseau MR; Bernard P
Leukemia; 1997 Nov; 11(11):1878-86. PubMed ID: 9369421
[TBL] [Abstract][Full Text] [Related]
14. [CD45-gating for flow cytometric immunophenotyping of leukemia].
Cui W; Ma W; Lin Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):199-203. PubMed ID: 12903529
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study on prognosis of acute leukemia subtypes Ly + AML and My + ALL].
Liu B; Li R; Wu HJ; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):421-4. PubMed ID: 17493361
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation.
Krasinskas AM; Wasik MA; Kamoun M; Schretzenmair R; Moore J; Salhany KE
Am J Clin Pathol; 1998 Dec; 110(6):797-805. PubMed ID: 9844593
[TBL] [Abstract][Full Text] [Related]
18. Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category.
Weinberg OK; Hasserjian RP; Li B; Pozdnyakova O
J Clin Pathol; 2017 Feb; 70(2):109-115. PubMed ID: 27387988
[TBL] [Abstract][Full Text] [Related]
19. Minimal screening analysis based algorithm for diagnosis and clinical stratification of patients with acute myeloid leukaemia (AML): single centre experience.
Panovska-Stavridis I; Trajkova S; Ivanovski M; Hadzi-Pecova L; Dukovski D; Popova-Simjanovska M; Cevreska L
Prilozi; 2012; 33(1):93-106. PubMed ID: 22952097
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
